The essential role of recombinant phage display antibody libraries
Drug Target Review
OCTOBER 3, 2024
Since the 1970s, when hybridoma technology enabling the generation of monoclonal antibodies (mAbs) was first developed, 1 antibody-based therapeutics have become one of the most rapidly growing drug categories, with applications across cancer indications, immune disorders and infections. Antibodies to watch in 2024. 2024 Jan 5;16(1).
52 
Let's personalize your content